Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

Social Security no taxes message on Trump bill raises eyebrows All About Lady Gaga's $1 Million Engagement Ring (and the ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

China has launched a controversial new civilian flight path near Taiwan, saying the route will reduce air traffic congestion. But Taiwan warns the move could further escalate tensions in the region.

Out to make a bigger difference, Alphabet’s Isomorphic Labs is exploring a much more useful application of AI. The Google ...